Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Bradley Haverkos

Concepts (181)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lymphoma, T-Cell
8
2024
31
2.870
Why?
Lymphoma, T-Cell, Peripheral
6
2024
19
2.610
Why?
Lymphoma
5
2023
251
1.750
Why?
Skin Neoplasms
7
2026
806
1.690
Why?
Lymphoma, Extranodal NK-T-Cell
4
2024
11
1.660
Why?
Lymphoma, T-Cell, Cutaneous
6
2023
43
1.600
Why?
Herpesvirus 4, Human
6
2023
172
1.460
Why?
Epstein-Barr Virus Infections
5
2023
102
1.420
Why?
Hematopoietic Stem Cell Transplantation
10
2024
704
1.370
Why?
Mycosis Fungoides
3
2026
63
1.280
Why?
Lymphoma, Large B-Cell, Diffuse
8
2025
195
1.260
Why?
Antineoplastic Agents, Immunological
2
2026
200
1.250
Why?
Transplantation Conditioning
10
2024
193
1.210
Why?
Sezary Syndrome
2
2026
45
1.150
Why?
Lymphoma, B-Cell
6
2026
150
1.140
Why?
Antibodies, Monoclonal, Humanized
4
2026
992
1.090
Why?
Programmed Cell Death 1 Receptor
3
2018
268
1.000
Why?
Lymphoma, Non-Hodgkin
3
2023
124
0.990
Why?
Hematopoietic Stem Cell Mobilization
2
2017
28
0.910
Why?
Hodgkin Disease
2
2018
173
0.900
Why?
Graft vs Host Disease
6
2024
283
0.740
Why?
Immunotherapy, Adoptive
6
2026
356
0.730
Why?
Smiling
1
2021
6
0.700
Why?
Thrombocytopenia
1
2023
206
0.690
Why?
DNA, Viral
3
2017
354
0.640
Why?
Prognosis
10
2026
4351
0.620
Why?
Face
1
2021
177
0.620
Why?
Cord Blood Stem Cell Transplantation
4
2024
103
0.600
Why?
Natural Killer T-Cells
1
2020
71
0.590
Why?
Hematology
1
2019
21
0.570
Why?
Antigens, CD19
5
2026
137
0.570
Why?
B7-H1 Antigen
1
2020
245
0.540
Why?
Heterocyclic Compounds
2
2017
23
0.530
Why?
Neoplasm Recurrence, Local
9
2024
1160
0.530
Why?
Central Nervous System Neoplasms
3
2024
177
0.500
Why?
Burkitt Lymphoma
3
2021
61
0.480
Why?
Antineoplastic Combined Chemotherapy Protocols
9
2024
1998
0.450
Why?
Neoplasm Proteins
1
2018
444
0.430
Why?
Antineoplastic Agents
7
2023
2219
0.430
Why?
Peripheral Blood Stem Cell Transplantation
1
2014
35
0.410
Why?
Treatment Outcome
15
2026
11821
0.410
Why?
Adult
26
2026
41087
0.410
Why?
Antibodies, Monoclonal
3
2023
1512
0.400
Why?
Viral Load
1
2016
526
0.400
Why?
Humans
53
2026
146342
0.400
Why?
Rituximab
7
2024
208
0.390
Why?
Remission Induction
4
2024
308
0.380
Why?
Aged, 80 and over
11
2026
8391
0.370
Why?
Aged
22
2026
26432
0.370
Why?
Middle Aged
26
2026
36619
0.370
Why?
Mediastinal Neoplasms
2
2025
54
0.340
Why?
Survival Analysis
6
2020
1378
0.310
Why?
Transplantation, Homologous
4
2019
416
0.300
Why?
T-Lymphocytes
3
2026
2012
0.290
Why?
Immunoblastic Lymphadenopathy
2
2022
2
0.290
Why?
Retrospective Studies
13
2026
17438
0.290
Why?
Transplantation, Autologous
3
2020
306
0.280
Why?
Recurrence
6
2024
1133
0.250
Why?
Salvage Therapy
2
2019
166
0.250
Why?
Male
24
2026
73396
0.240
Why?
Autografts
2
2019
56
0.240
Why?
Anti-HIV Agents
1
2014
914
0.240
Why?
Benzylamines
2
2017
44
0.230
Why?
Lymphoma, B-Cell, Marginal Zone
2
2015
21
0.230
Why?
Female
22
2026
79499
0.220
Why?
Cyclophosphamide
5
2024
275
0.220
Why?
Transplantation, Haploidentical
1
2024
23
0.210
Why?
Depsipeptides
1
2024
15
0.200
Why?
Benzopyrans
1
2024
31
0.200
Why?
Myeloablative Agonists
2
2020
23
0.190
Why?
Immunotoxins
1
2023
51
0.190
Why?
Purines
1
2024
188
0.180
Why?
Disease-Free Survival
3
2021
778
0.180
Why?
Etoposide
4
2024
169
0.180
Why?
Young Adult
11
2025
14330
0.180
Why?
Histone Deacetylase Inhibitors
1
2023
219
0.170
Why?
Allografts
2
2020
151
0.160
Why?
Killer Cells, Natural
2
2024
481
0.160
Why?
Doxorubicin
4
2024
416
0.160
Why?
United States
6
2026
16136
0.160
Why?
Prospective Studies
4
2022
8123
0.150
Why?
Vincristine
3
2024
148
0.140
Why?
Combined Modality Therapy
3
2016
1271
0.140
Why?
Prednisone
3
2024
229
0.140
Why?
Thiotepa
1
2018
21
0.140
Why?
Lymphoproliferative Disorders
1
2018
59
0.130
Why?
Cytomegalovirus Infections
1
2019
206
0.130
Why?
Central Nervous System Diseases
1
2018
73
0.130
Why?
Antigens, CD34
1
2017
89
0.120
Why?
Asparaginase
1
2016
34
0.120
Why?
Carcinogenesis
1
2018
226
0.120
Why?
Granulocyte Colony-Stimulating Factor
1
2017
90
0.120
Why?
In Situ Hybridization
1
2017
317
0.120
Why?
Biopsy
2
2018
1075
0.120
Why?
Cell Count
1
2017
315
0.120
Why?
Tumor Microenvironment
1
2020
747
0.120
Why?
North America
1
2016
300
0.110
Why?
Drug Resistance, Neoplasm
2
2019
893
0.110
Why?
Lymphoma, Large-Cell, Anaplastic
1
2016
23
0.110
Why?
Europe
1
2016
421
0.110
Why?
HIV Infections
2
2021
3215
0.110
Why?
Immunosuppressive Agents
1
2020
829
0.110
Why?
Neoplasm Staging
2
2016
1488
0.110
Why?
Immunotherapy
1
2020
671
0.110
Why?
Ohio
1
2015
136
0.110
Why?
Biomarkers
2
2016
4340
0.110
Why?
Drug Resistance
1
2015
145
0.110
Why?
Follow-Up Studies
3
2024
5439
0.100
Why?
Practice Guidelines as Topic
2
2020
1591
0.100
Why?
Hematopoietic Stem Cells
1
2017
432
0.100
Why?
Adolescent
5
2024
22557
0.090
Why?
B-Lymphocytes
1
2018
887
0.090
Why?
Registries
4
2025
2400
0.090
Why?
Gene Expression
1
2017
1463
0.090
Why?
Academic Medical Centers
1
2015
561
0.090
Why?
Medicare
1
2018
920
0.090
Why?
Skin
1
2016
701
0.090
Why?
Genomics
1
2017
853
0.080
Why?
Proto-Oncogene Proteins c-myc
2
2023
157
0.080
Why?
Gene Expression Regulation, Neoplastic
1
2017
1432
0.080
Why?
Melphalan
2
2020
43
0.080
Why?
Gene Expression Profiling
1
2017
1792
0.080
Why?
Biomarkers, Tumor
1
2017
1339
0.080
Why?
Positron Emission Tomography Computed Tomography
2
2024
122
0.070
Why?
Vidarabine
2
2020
32
0.070
Why?
Whole-Body Irradiation
2
2020
73
0.070
Why?
Fetal Blood
2
2020
325
0.070
Why?
Kaplan-Meier Estimate
2
2021
970
0.060
Why?
Cohort Studies
3
2021
6077
0.060
Why?
Lactate Dehydrogenases
1
2023
5
0.050
Why?
Neoplasm Grading
1
2024
313
0.050
Why?
Neoplasm, Residual
1
2024
143
0.050
Why?
Disease Management
2
2018
651
0.050
Why?
Proto-Oncogene Proteins c-bcl-2
1
2023
237
0.040
Why?
Time-to-Treatment
1
2024
257
0.040
Why?
Interleukin-2
1
2023
434
0.040
Why?
Feasibility Studies
1
2026
1135
0.040
Why?
L-Lactate Dehydrogenase
1
2021
113
0.040
Why?
Busulfan
1
2020
15
0.040
Why?
Aminoquinolines
1
2020
18
0.040
Why?
United Kingdom
1
2021
377
0.040
Why?
Carmustine
1
2020
52
0.040
Why?
Gene Rearrangement
1
2021
156
0.040
Why?
Cytarabine
1
2020
66
0.040
Why?
Acetates
1
2019
78
0.040
Why?
Survival Rate
1
2024
2092
0.040
Why?
Central Nervous System
1
2021
278
0.040
Why?
Treatment Failure
1
2020
361
0.040
Why?
Viral Tropism
1
2018
38
0.030
Why?
Pilot Projects
1
2024
1888
0.030
Why?
Ganciclovir
1
2018
51
0.030
Why?
Guidelines as Topic
1
2020
267
0.030
Why?
Quinazolines
1
2019
267
0.030
Why?
Virus Latency
1
2018
93
0.030
Why?
Zidovudine
1
2018
75
0.030
Why?
Virus Activation
1
2018
97
0.030
Why?
Stem Cell Transplantation
1
2019
190
0.030
Why?
Standard of Care
1
2016
81
0.030
Why?
Multivariate Analysis
1
2020
1543
0.030
Why?
Mice, Inbred BALB C
1
2018
1244
0.030
Why?
Dexamethasone
1
2018
368
0.030
Why?
Positron-Emission Tomography
1
2017
343
0.030
Why?
Receptors, Interleukin-6
1
2015
49
0.030
Why?
Organ Transplantation
1
2018
244
0.030
Why?
Steroids
1
2015
160
0.030
Why?
Immunohistochemistry
1
2018
1712
0.030
Why?
Antiviral Agents
1
2019
779
0.020
Why?
Mice
2
2023
18297
0.020
Why?
Clinical Decision-Making
1
2016
365
0.020
Why?
Databases, Factual
1
2018
1493
0.020
Why?
Mice, Knockout
1
2018
3125
0.020
Why?
Leukemia, Myeloid, Acute
1
2018
702
0.020
Why?
Diagnosis, Differential
1
2015
1503
0.020
Why?
Age Factors
1
2018
3347
0.020
Why?
Biomedical Research
1
2016
729
0.020
Why?
Risk Factors
1
2024
10921
0.020
Why?
Animals
2
2023
38107
0.020
Why?
Disease Models, Animal
1
2018
4580
0.020
Why?
Tomography, X-Ray Computed
1
2018
2786
0.020
Why?
Risk Assessment
1
2016
3712
0.020
Why?
Child
1
2024
22693
0.010
Why?
Haverkos's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)